Skip to content

PCMA’s Merritt issues statement on drug pricing

Pharmaceutical Care Management Association (PCMA) president and chief executive officer Mark Merritt released the following statement on reports of yet another round of massive price hikes by drug manufacturers.

Table of Contents

WASHINGTON — Pharmaceutical Care Management Association (PCMA) president and chief executive officer Mark Merritt released the following statement on reports of yet another round of massive price hikes by drug manufacturers.

“News of recent price increases by drugmakers further confirms that the easiest way to lower costs would be for drug companies to lower their prices.”

This news follows an Office of Inspector General, Health and Human Services report that debunked the myth that drugmakers have somehow been compelled to raise prices because of the discounts and rebates health plans and PBMs demand to reduce overall costs.”

Comments

Latest